Filing Flows › Steris (STE) › Q2 FY27 › vs Q2 FY26
Steris (STE) Q2 FY27 vs Q2 FY26 (year over year)
Steris's revenue rose $128M (+9%) from $1.5B in Q2 FY26 to $1.6B in Q2 FY27. The biggest changes: Healthcare +$88.6M (+9%); Life Sciences: +$25.6M (+18%); AST +$14.1M (+5%). Gross margin 44.7% against 44.2% (+0.5 pts).
Steris, Q2 FY27: revenue $1.6B (+9% year over year), operating margin 18.5%, net earnings $214M, operating cash flow $289M. The chart draws each line against Q2 FY26, the increases inside each band.
Margins
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Gross margin | 44.7% | 44.2% | +0.5 pts |
| Operating margin | 18.5% | 18.2% | +0.3 pts |
| Net margin | 13.5% | 13.2% | +0.3 pts |
| Free cash flow margin | 13.4% | 13.8% | -0.4 pts |
Every line
| Line | Q2 FY27 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Healthcare | $1.1B | $1.0B | $88.6M | +9% |
| AST | $296M | $282M | $14.1M | +5% |
| Life Sciences: | $171M | $145M | $25.6M | +18% |
| Revenue | $1.6B | $1.5B | $128M | +9% |
| Gross profit | $711M | $646M | $64.9M | +10% |
| Cost of revenue | $878M | $814M | $63.4M | +8% |
| Operating profit | $294M | $266M | $28.5M | +11% |
| Operating expenses | $416M | $380M | $36.4M | +10% |
| Pre-tax earnings | $288M | $253M | $34.9M | +14% |
| Other expense, net | $6.3M | $12.7M | −$6.4M | -50% |
| Research & development | $31.5M | $28.2M | $3.3M | +12% |
| SG&A | $366M | $350M | $16.3M | +5% |
| Other operating costs | $19.0M | $2.2M | $16.8M | +764% |
| Net earnings | $214M | $192M | $21.6M | +11% |
| Income tax | $73.9M | $60.6M | $13.3M | +22% |
| Depreciation & amortization | $126M | $122M | $3.9M | +3% |
| Share-based compensation | $21.7M | $21.2M | $500K | +2% |
| Working capital & other | $72.4M | $47.6M | $24.8M | +52% |
| Operating cash flow | $289M | $288M | $1.2M | +0.4% |
| Free cash flow (OCF − capex) | $213M | $201M | $11.6M | +6% |
| Capital expenditures | $76.1M | $86.5M | −$10.4M | -12% |
Questions
How much did Steris's revenue grow year over year in Q2 FY27?
Steris's revenue rose $128M (+9%) from $1.5B in Q2 FY26 to $1.6B in Q2 FY27.
What drove Steris's revenue change in Q2 FY27?
Healthcare +$88.6M (+9%); Life Sciences: +$25.6M (+18%); AST +$14.1M (+5%).